October 25, 2017 21:00 - 22:00 UTC
Emmanuel Favoloro "Pre-analytical issues in laboratory testing for thrombosis and hemostasis related assays"
This presentation will cover pre-analytical issues related to hemostasis testing, meaning issues that affect hemostasis test results , but which are due to events that occur prior to the analytical testing. These events may occur during blood collection, processing or storage, or even beforehand.
Target Audience:
This presentation is intended for anyone involved in the process of hemostasis testing unfamiliar with pre-analytical issues, including blood collectors (phlebotomists), nursing staff involved in hemophilia care, scientists involved in hemostasis testing, and clinicians with an interest in identifying why hemostasis test results sometimes do not match expectations – be they hematology trainees/registrars or even more experienced.
Learning objective:
- Upon completion of this activity, participants should be able to identify and resolve issues that contribute to ‘incorrect’ or unexpected hemostasis test results, including problematic blood collections, inappropriate blood processing, and poor patient/test selection.
Andrew "Larry" Frelinger III "Platelet testing and point of care tests"
Platelet testing is important in the diagnosis of inherited or acquired platelet function defects and has been increasingly used in clinical trials to monitor the pharmacodynamic effect of antiplatelet agents. Pre-analytical issues affecting common laboratory platelet function tests will be discussed. Specific pre-analytical issues relevant to platelet testing in multi-centered clinical trials will also be considered.
Supported by an unrestricted educational grant from Instrumentation Laboratory
Clinicians, researchers, and students in the fields of thrombosis and hemostasis
At the end of this Webinar, the participants will be able to:
- Identify common pre-analytical pitfalls in sample collection for platelet function testing
- Identify advantages and disadvantages of light transmittance aggregometry vs. whole blood impedance aggregometry
- Identify appropriate methods for assessing platelet function in thrombocytopenic samples
- Understand how the logistical constraints of clinical research trials limit control of pre-analytical variables for platelet function testing
Speakers:
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:
Name | Company | Role |
Geoffrey Barnes, MD | BMS/Pfizer, Blue Cross Blue Shield of MI, Aralez | Research Grant, Consulting |
Andrew "Larry" Frelinger III, PhD | Baxalta, Eisai, Medtronic, Ionis, Ironwood, Pfizer, Sysmex | Investigator |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.